clofibrate has been researched along with atrial natriuretic factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haniu, K; Iitake, K; Inoue, M; Kimura, T; Matsui, K; Ota, K; Ota, M; Sato, K; Shoji, M; Yoshinaga, K | 1 |
| Cano-Martínez, A; Castrejón-Téllez, V; Díaz-Díaz, E; Ibarra-Lara, L; Osorio-Yáñez, C; Pavón, N; Rubio-Ruíz, ME; Sánchez-Aguilar, M; Soria-Castro, E | 1 |
2 other study(ies) available for clofibrate and atrial natriuretic factor
| Article | Year |
|---|---|
[A case of postoperative craniopharyngioma with hypernatremia. The mechanisms of ADH and atrial natriuretic peptide (ANP) releases].
Topics: Atrial Natriuretic Factor; Clofibrate; Craniopharyngioma; Female; Humans; Hydrocortisone; Hypernatremia; Middle Aged; Pituitary Neoplasms; Postoperative Complications; Vasopressins | 1988 |
PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response.
Topics: Animals; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Clofibrate; Inflammation; Ischemia; Metabolic Syndrome; Natriuretic Peptides; PPAR alpha; Rats; Receptors, Atrial Natriuretic Factor; Reperfusion Injury | 2023 |